InsidersTradesSigma
알테오젠 Stock: price and insider trades · South Korea · DART (FSS)
Track the 알테오젠 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 알테오젠 has recorded 2 reports. Market capitalisation: €16,748.7bn. The latest transaction was reported on 7 April 2026 (Sale). Among the most active insiders: 박순재. All data is openly available.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
1 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,752 of 28,064 companies
66.5
score / 100
Value40
Quality93
FCF yld0.5%
Earn yld0.8%
EV/EBITDA·
ROE25%
Gross mgn77%
Net mgn66%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 7 April 2026
About 알테오젠
Alteogen is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development of innovative biopharmaceuticals.